Product Name
Leucine Rich Repeat Kinase 2 (LRRK2), Polyclonal Antibody
Full Product Name
Biotin-Linked Antibody to Leucine Rich Repeat Kinase 2 (LRRK2)
Product Gene Name
anti-LRRK2 antibody
[Similar Products]
Matching Pairs
Biotin Conjugated Antibody: Leucine Rich Repeat Kinase 2 (LRRK2) (MBS2003244)
Immunogen: Leucine Rich Repeat Kinase 2 (LRRK2) (MBS2012043)
Matching Pairs
Unconjugated Antibody: Leucine Rich Repeat Kinase 2 (LRRK2) (MBS2005994)
Biotin Conjugated Antibody: Leucine Rich Repeat Kinase 2 (LRRK2) (MBS2003244)
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Chromosome Location
Chromosome: 12; NC_000012.11 (40618813..40763087). Location: 12q12
3D Structure
ModBase 3D Structure for Q5S007
Specificity
The antibody is a rabbit polyclonal antibody raised against LRRK2 conjugated to biotin. It has been selected for its ability to recognize LRRK2 in immunohistochemical staining andwestern blotting.
Purity/Purification
Affinity Chromatography
Form/Format
Supplied as solution form in PBS, pH7.4, containing 0.02% NaN3,50% glycerol.
Concentration
200ug/ml (lot specific)
Preparation and Storage
Store at 4 degree C for frequent use. Stored at -20 degree C to -80 degree C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
ISO Certification
Manufactured in an ISO 9001:2008 and ISO 13485:2003 Certified Laboratory.
Supply Chain Verification
Manufactured in a lab with traceable raw materials. Bulk orders can typically be prepared to the customera??s specifications, please inquire.
Other Notes
Small volumes of anti-LRRK2 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Product Categories/Family for anti-LRRK2 antibody
Biotin Antibody
Applications Tested/Suitable for anti-LRRK2 antibody
Immunohistochemistry (IHC), ELISA (EIA), Western Blot (WB)
Application Notes for anti-LRRK2 antibody
Western blotting: 1:100-400
Immunocytochemistry in formalin fixed cells: 1:100-500
Immunohistochemistry in formalin fixed frozen section: 1:100-500
Immunohistochemistry in paraffin section: 1:50-200
Enzyme-linked Immunosorbent Assay: 1:100-200
NCBI/Uniprot data below describe general gene information for LRRK2. It may not necessarily be applicable to this product.
NCBI Accession #
AAI17181.1
[Other Products]
UniProt Primary Accession #
Q5S007
[Other Products]
UniProt Secondary Accession #
Q6ZS50; Q8NCX9; A6NJU2[Other Products]
UniProt Related Accession #
Q5S007[Other Products]
Molecular Weight
286,103 Da
NCBI Official Full Name
Leucine-rich repeat kinase 2
NCBI Official Synonym Full Names
leucine-rich repeat kinase 2
NCBI Official Symbol
LRRK2??[Similar Products]
NCBI Official Synonym Symbols
PARK8; RIPK7; ROCO2; AURA17; DARDARIN
??[Similar Products]
NCBI Protein Information
leucine-rich repeat serine/threonine-protein kinase 2; augmented in rheumatoid arthritis 17
UniProt Protein Name
Leucine-rich repeat serine/threonine-protein kinase 2
UniProt Synonym Protein Names
Dardarin
Protein Family
Leucine-rich repeat serine/threonine-protein kinase
UniProt Gene Name
LRRK2??[Similar Products]
UniProt Synonym Gene Names
PARK8??[Similar Products]
UniProt Entry Name
LRRK2_HUMAN
NCBI Summary for LRRK2
This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008]
UniProt Comments for LRRK2
LRRK2: a large multidomain protein kinase with a TKL-type kinase domain, multiple protein-protein interaction domains and a mitochondrial Rho domain (MIRO). May play a role in the etiology of Parkinson disease. May also have GTPase activity. Positively regulates autophagy through a calcium-dependent activation of the CaMKK/AMPK signaling pathway. The process involves activation of nicotinic acid adenine dinucleotide phosphate (NAADP) receptors, increase in lysosomal pH, and calcium release from lysosomes. Interacts with PARK2, PRDX3 and TPCN2. Expressed throughout the ***** brain, but at a lower level than in heart and liver. Expressed in the cerebellum, cerebral cortex, medulla, spinal cord occipital pole, frontal lobe, temporal lobe and putamen. Expression is particularly high in brain dopaminoceptive areas. Defects in LRRK2 are the cause of Parkinson disease type 8 (PARK8). A slowly progressive neurodegenerative disorder characterized by bradykinesia, rigidity, resting tremor, postural instability, neuronal loss in the substantia nigra, and the presence of neurofibrillary MAPT (tau)-positive and Lewy bodies in some patients.
Protein type: Kinase, protein; Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; Protein kinase, TKL; TKL group; LRRK family
Chromosomal Location of Human Ortholog: 12q12
Cellular Component: dendrite cytoplasm; Golgi apparatus; extracellular space; neuron projection; mitochondrion; synaptic vesicle membrane; endoplasmic reticulum; lysosome; dendrite; terminal button; perikaryon; inclusion body; trans-Golgi network; cytosol; lipid raft; mitochondrial outer membrane; cell soma; mitochondrial matrix; axon; mitochondrial inner membrane; mitochondrial membrane; cytoplasm; plasma membrane; cytoplasmic vesicle; cell junction; endosome
Molecular Function: tubulin binding; GTPase activity; identical protein binding; clathrin binding; GTP-dependent protein kinase activity; Rho GTPase binding; protein homodimerization activity; GTP binding; actin binding; GTPase activator activity; protein kinase activity; MAP kinase kinase activity; protein serine/threonine kinase activity; protein binding; SNARE binding; protein kinase A binding; syntaxin-1 binding; kinase activity; glycoprotein binding; ATP binding
Biological Process: regulation of synaptic transmission, glutamatergic; activation of MAPKK activity; positive regulation of protein binding; activation of MAPK activity; protein amino acid autophosphorylation; regulation of neuron maturation; determination of ***** life span; protein amino acid phosphorylation; positive regulation of MAP kinase activity; tangential migration from the subventricular zone to the olfactory bulb; negative regulation of protein amino acid phosphorylation; small GTPase mediated signal transduction; regulation of dopamine receptor signaling pathway; negative regulation of protein binding; regulation of mitochondrial depolarization; neuromuscular junction development; positive regulation of autophagy; positive regulation of dopamine receptor signaling pathway; olfactory bulb development; MAPKKK cascade; peptidyl-threonine phosphorylation; endocytosis; regulation of locomotion; regulation of membrane potential; positive regulation of programmed cell death; peptidyl-serine phosphorylation; positive regulation of protein ubiquitination; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; intracellular distribution of mitochondria; autophagy; response to oxidative stress; positive regulation of protein amino acid phosphorylation; regulation of excitatory postsynaptic membrane potential; neurite morphogenesis; positive regulation of GTPase activity
Disease: Parkinson Disease 8, Autosomal Dominant
Research Articles on LRRK2
1. The findings of this study suggested that 22q11.2 deletions represent a novel genetic risk factor for early-onset PD with variable neuropathological presentation reminiscent of LRRK2-associated PD neuropathology
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.